【レポートの概要（一部）】
1. Report Overview
1.1 Overview of the World Market for Pharma Clinical Trial Services
1.2 Why Should You Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analysis
1.5 Who Is This Study For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
2. An Introduction to Clinical Trial Outsourcing
2.1 A Brief History of Clinical Trials
2.2 Clinical Trial Design and Execution
2.2.1 Phases of Clinical Trials
2.2.1.1 Phase I Trials: First-In-Human Studies
2.2.1.2 Phase II Trials: Proof-Of-Concept
2.2.1.3 Phase III Trials: Preparing for Approval Applications
2.2.1.4 Post-Marketing Studies
2.2.2 Key Elements of Clinical Trials
2.2.3 Common Trial Designs
2.2.3.1 Improving Clinical Trial Models through Adaptive Trial Designs
2.3 Clinical Trial Outsourcing
2.3.1 Challenges Exist in Conducting Clinical Trials
2.3.2 Benefits of Outsourcing
3. Pharma Clinical Trial Services: World Market 2015-2025
3.1 The World Pharma Clinical Trial Services Market in 2013 and 2014
3.1.1 The Impact of the Economy on the Clinical Trial Services Market, 2008-2014
3.1.2 CRO Revenue by Trial Phase 2014
3.1.3 Big Pharma Companies Are the Leading Clients for CROs
3.2 The Pharma Clinical Trial Services Market 2015-2025
3.2.1 What Will Drive Growth in Clinical Trial Outsourcing 2015-2025?
3.2.2 The Pharma Clinical Trial Services Market: Overall Revenue Forecast 2015-2025
3.2.3 Which Market Sector Will Account for the Most Revenue from 2015-2025?
3.3 Early Phase Clinical Trial Services 2015-2025
3.3.1 Rising Demand for Early Phase Services throughout the Decade
3.3.2 Biotech Outsourcing to Drive Early Phase Growth
3.4 Late Phase Clinical Trial Services 2015-2025
3.4.1 Late Phase Clinical Trial Services: The Largest Market Sector 2015-2025
3.4.2 Focus on Late-Stage Pipeline Candidates Early in the Decade
4. Pharma Clinical Trial Services: Leading Developed National Markets 2015-2025
4.1 Leading National Markets for Pharma Clinical Trial Services 2014
4.2 Pharma Clinical Trial Services: Leading National Market Forecasts 2015-2025
4.3 North America as a Destination for Clinical Trials
4.3.1 The US: The Largest National Market for Clinical Trial Services 2015-2025
4.3.1.1 Regulatory Developments to Improve Clinical Trials in the US
4.3.2 The US: Clinical Trial Service Revenue Forecast 2015-2025
4.4 The Outlook for Clinical Trial Services in the EU5 2015-2025
4.4.1 Rewriting the Rules for Clinical Trials in the EU: Clinical Trials Regulation
4.4.2 EU5: Overall Market and Leading National Market Forecasts 2015-2025
4.4.3 Germany Is the Largest Market for Clinical Trial Services in Western Europe
4.4.4 The UK
4.4.4.1 Overcoming Challenges in UK Clinical Trials
4.4.4.2 UK Clinical Trial Services Market Forecast 2015-2025
4.4.5 France: Market Forecast 2015-2025
4.4.6 Italy: Market Forecast 2015-2025
4.4.7 Spain: Market Forecast 2015-2025
4.5 Japan Is Being Challenged by Neighbouring Emerging Markets
4.5.1 Regulatory Policies Driving and Restraining Growth in Japan
4.5.2 Growth for Clinical Trial Services in Japan 2015-2025
5. Pharma Clinical Trial Services: Leading Emerging National Markets 2015-2025
5.1 Leading Emerging Markets for Clinical Trial Services 2014
5.1.1 Benefits of Conducting Clinical Trials in Emerging Markets
5.1.2 Challenges of Conducting Clinical Trials in Emerging Markets
5.2 Strong Growth Forecast for Emerging Clinical Trial Service Markets 2015-2025
5.3 Clinical Trials in Asia Pacific: An Emerging Market Perspective
5.3.1 China Will be the Largest Emerging Market for Clinical Trials Services in 2025
5.3.1.1 CRO Investments and Partnerships in China
5.3.1.2 Chinese Clinical Trial Services Market Forecast 2015-2025
5.3.1.3 China Offers Many Advantages in Clinical Trials
5.3.1.4 New Guidelines by the China Food and Drug Administration (CFDA)
5.3.2 India as a Hub for Clinical Trials
5.3.2.1 Increasingly Strict Regulatory Procedures in India
5.3.2.2 Indian Clinical Trial Services Market Forecast 2015-2025
5.3.3 South Korea
5.3.3.1 Improving the Appeal of South Korea
5.3.3.2 Promoting Local Drug Development in South Korea
5.3.3.3 Growth in the South Korean Clinical Trials Services Market 2015-2025
5.4 Clinical Trial Outsourcing in Central and Eastern Europe (CEE)
5.4.1 Russia
5.4.1.1 Changing Clinical Trial Demands 2010-2015
5.4.1.2 Russian Clinical Trial Services Market Forecast 2015-2025
5.4.2 CEE: Clinical Trial Services Market Forecast 2015-2025
5.5 Latin America: Proximity to the US as a Growth Driver
5.5.1 Brazil: The Largest Market for Clinical Trials in Latin America 2015-2025
5.5.1.1 Brazilian Clinical Trial Services Market Forecast 2015-2025
6. Leading Disease Market Sectors for Clinical Trial Services 2015-2025
6.1 Rise in Clinical Trials, 2000-2015
6.2 The Pharma Clinical Trial Services Market by Therapeutic Area 2014-2015
6.3 The Pharma Clinical Trial Services Market: Revenue Forecasts by Therapeutic Area 2015-2025
6.3.1 Imaging for CNS and Cardiovascular Clinical Trials
6.4 Cancer Clinical Trials: Key Trends and Submarket Forecast 2015-2025
6.4.1 Biomarkers and Companion Diagnostic Development
6.4.2 Optimising Patient Recruitment and Retention
6.4.3 Many Factors Complicate Cancer Clinical Trials
6.4.4 Will Cancer Be the Largest Submarket for Clinical Trial Services 2015-2025?
6.5 Cardiovascular Disease Clinical Trials: Key Trends and Submarket Forecast 2015-2025
6.5.1 Strong Growth in the Cardiovascular Disease Clinical Trial Services Submarket 2015-2025
6.6 CNS Clinical Trials: Key Trends and Submarket Forecast 2015-2025
6.6.1 Late-Stage Failures in Alzheimer’s Pipeline, 2009-2014
6.6.2 Concerns with Placebo Response Rates in CNS Clinical Trials
6.6.2.1 Cogtest Clinical: Data Capture and Cognitive Assessment
6.6.3 Effective Use of Adaptive Trial Designs
6.6.4 CNS Clinical Trials: Submarket Forecast 2015-2025
6.7 Infectious Disease Clinical Trials: Key Trends and Submarket Forecast 2015-2025
6.7.1 Challenges in the Use of Non-Inferiority Trials
6.7.2 Considerations for Antibacterial Drug Clinical Trials
6.7.3 Vaccine Clinical Trials and Emerging Markets
6.7.4 Infectious Disease Clinical Trial Services Submarket Forecast 2015-2025
6.8 Metabolic Disease Clinical Trials: Key Trends and Submarket Forecast 2015-2025
6.8.1 Assessing Cardiovascular Risks in Diabetes
6.8.2 Metabolic Disease Clinical Trial Services Submarket Forecast 2015-2025
6.9 Therapeutic Expertise Provides an Opportunity for Specialisation
6.9.1 CROs Offering Imaging Services
7. Pharma Clinical Trial Services Market: Industry Trends 2015-2025
7.1 Pharma Clinical Trial Services Market: Strengths and Weaknesses 2014
7.2 Pharma Clinical Trial Services Market: Opportunities and Threats 2015-2025
7.2.1 Opportunities for CROs in Biosimilar Development
7.3 Pharma Clinical Trial Services Market: STEP Analysis 2015-2025
7.4 Social Factors Affecting Clinical Trials 2015-2025
7.4.1 Drug Developers Must Deal with Ethical Considerations to Clinical Trials
7.4.2 Patient Recruitment: The Leading Cause of Trial Delays
7.4.3 Investing to Maintain Patient Enrolment
7.4.3.1 Social Media as a Tool for Engaging Patients in Trials
7.5 Improving Technology for More-Efficient Trials
7.5.1 eClinical Trial Tools
7.5.1.1 Electronic Health Records for Faster Patient Recruitment
7.5.2 Cloud Computing as a Tool for Multicentre Trials
7.5.3 Electronic Data Capture
7.6 Economic Considerations for Clinical Trial Outsourcing
7.6.1 Pharma is Adjusting its R&D Strategies
7.6.2 CROs are Attractive for Private Investors
7.7 Political and Regulatory Developments Affecting Clinical Trials
7.7.1 Drug Safety and Clinical Trials Post-Approval
7.7.2 Cutting Red Tape and Other Regulatory Developments
7.8 Future Growth Strategies for CROs
7.8.1 Strategic Partnering for Long Term Revenue Growth
7.8.1.1 Sharing Risk Between Pharma and CROs
7.8.2 What Strategies Are Used for Selecting a CRO?
7.8.2.1 Small Pharmaceutical Companies and CROs
7.8.3 CRO Consolidation is Decreasing the Number of Mid-Sized Market Players
7.8.4 CROs Can Specialise to Grow
7.8.4.1 Orphan Diseases Are an Opportunity for Specialisation
7.9 The Future of Clinical Trials and CROs
7.9.1 New Trial Designs
7.9.1.1 Optimising Clinical Trials for Efficient Drug Development
7.9.2 Clinical Trial Globalisation
7.9.2.1 Consequences of Increased Outsourcing to Emerging Markets
7.9.3 Clinical Trials Have Become Increasingly Complex
7.10 Biomarkers Are Useful Tools for Accelerating Drug Development
8. Leading CROs in the Clinical Trials Services Industry in 2015
8.1 The Pharma Clinical Trial Services Market by Company 2014
8.2 Quintiles: The Largest Player in the Pharma Clinical Trial Services Market
8.2.1 Embracing Technology for New Service Offerings
8.2.2 How Quintiles Remains a Leader in the Clinical Trials Market
8.2.2.1 An Increase in Emerging Biotech Customers in 2014
8.2.2.2 Expanding in Developed and Emerging Markets
8.2.3 Will Quintiles Remain the Market Leader to 2025?
8.3 Covance Acquired by Laboratory Corporation of America (LabCorp)
8.3.1 Covance Drug Development
8.3.2 Covance Reorganises its Early Phase Sites
8.3.3 Strong Late Phase Revenue Growth 2010-2014
8.3.4 How Will Covance Drug Development Extend its Services Beyond 2014?
8.4 Pharmaceutical Product Development (PPD)
8.4.1 PPD: Another Global CRO to be Taken Private
8.4.2 Investing in Technology for Growth
8.4.3 PPD: Outlook 2015-2025
8.5 Parexel International
8.5.1 Parexel is Targeting Growth in Asia
8.5.2 Strong Growth for Clinical Trial Services 2010-2014
8.5.3 New Areas of Specialisation for Parexel
8.6 ICON
8.6.1 Multiple Acquisitions Have Increased ICON’s Service Range
8.6.1.1 Expanding Operations in China
8.6.2 ICON: Recent Financial Performance and Outlook 2015-2025
8.7 INC Research
8.7.1 From Mid-Sized to Large CRO: INC Acquires Kendle
8.7.2 INC Adds New Technological Capabilities
8.8 inVentiv Health
8.8.1 Four Acquisitions Move inVentiv Closer to the Big Players
8.8.2 Clinical Trial Service Revenue Growth 2011 and Beyond
8.9 PRA Health Sciences
8.9.1 New Site Openings in Emerging Markets 2011-2014
8.9.2 Future Directions for PRA Health Sciences
8.10 CMIC Holdings: Japan’s Largest CRO
8.10.1 Increasing Asian Regional Reach
8.10.2 CMIC Recent and Future Performance Analysis: An Asian Specialist
8.11 Chiltern International
8.11.1 Expanding into New Emerging Markets with Expansion in Israel, Taiwan and Singapore
8.11.2 Chiltern International: Opportunities for Growth 2015-2025
8.12 There Are Many Other CROs in the Market in 2015
8.12.1 Charles River Laboratories Is an Expert in Pre-Clinical Services
8.12.2 Clinipace Worldwide Is a Digital CRO
8.12.2.1 Rapidly Expanding Through Acquisitions
8.12.2.2 Clinipace Offers Many Technology Solutions
8.12.3 Theorem Clinical Research
8.12.3.1 An Established Presence in China
8.12.4 WuXi PharmaTech
8.12.4.1 WuXi is New to the Clinical Trial Services Market
8.13 Leading Company Analysis
8.13.1 Emerging Market Entry and Expansion
8.13.2 How Are Global CROs Expanding Their Service Offerings and Utilising Technology?
8.13.3 How Are Leading Players Seeking to Differentiate Themselves?
8.13.4 Medium-Sized Players Growing Larger Through Multiple Acquisitions
8.13.5 Large CROs and Strategic Partnerships with Big Pharma
9. Research Interviews from Our Survey
9.1 Interview with Mark Egerton, CEO of Quotient Clinical
9.1.1 Quotient Clinical’s Translational Pharmaceutics Platform
9.1.2 Quotient Clinical in the Global Market
9.1.3 Challenges for the Pharma Clinical Trial Services Market
9.1.4 Pharma Clinical Trial Services Market Size, 2015-2025
9.2 Interview with Dean Knuth, Executive Director Clinical Sciences of MPI Research
9.2.1 On Changes in the Outsourcing Market
9.2.2 MPI Research Acquires Jasper Clinical
9.2.3 Future Outlook for MPI Research
9.2.4 Drivers and Restraints in Early Phase Clinical Trial Services
9.2.5 Technological Advances in Clinical Trials Services
9.2.6 On the Early Phase Development Market Size
9.3 Interview with Ewan Campbell, Director of The Clinical Trial Company
9.3.1 Clinical Trial Services Offered at TCTC
9.3.2 Drivers and Restraints for Outsourcing Late-Phase Development
9.3.3 Potential Impact of the EU Clinical Trial Regulation on the Clinical Trial Services
9.3.4 Trends Affecting the Clinical Trial Services Market, 2015-2025
10. Conclusions from Our Research and Analysis
10.1 The State of the Clinical Trial Services Market in 2014
10.1.1 A Market Dominated by the Developed Countries
10.2 Strong Growth for the Overall Market 2015-2025
10.3 Which CROs Can Take Best Advantage of Market Growth in the Next 10 Years?
10.3.1 The Role of Technology in the Future of Clinical Trial Services
10.3.2 How Can CROs Specialise to Remain Competitive?
【レポート販売概要】
■ タイトル：臨床試験アウトソーシングサービスの世界市場2015-2025■ 英文：Pharma Clinical Trial Services: World Industry and Market Prospects 2015-2025
■ 発行日：2015年6月
■ 調査会社：visiongain
■ 商品コード：VGAIN50614
■ 調査対象地域：グローバル
- 世界の天井仕上材市場：ミネラルウール、石膏、金属About Ceiling Tiles Ceiling tiles, also known as ceiling panels, absorb sound and lightweight construction materials used to cover a ceiling area. These tiles are placed in an aluminum grid to enhance room acoustics and provide thermal insulation, sound absorption, and fire insulation, mainly used in the interiors of buildings. The main raw materials used in manufacturing these tiles are gypsum, m …
- 豆乳の世界市場展望2017-20276According to Stratistics MRC, the Global Soy Milk market is accounted for $14.44 billion in 2017 and is expected to reach $28.40 billion by 2026 growing at a CAGR of 7.8%. The factors such as increasing demand for lactose-free food products due to the ease of digest which is likely to contribute significantly to the revenue growth of soy milk market. However, the exceptional taste of the soy milk …
- 世界の音声分析（スピーチ・アナリティクス）市場動向及び予測(2014-2019)The speech analytics market analysis consists of various types of solutions and services, applications, deployment types, organization size, verticals, and regions. The overall market size is found by adding up the market size of each solution and services such as speech engine, indexing and analysis, software query, engine reports and dashboards, professional services and support, maintenance ser …
- 再生可能エネルギー政策分析：June 2013Renewable Policy Analysis - June 2013 Summary The “Renewable Policy Analysis” provides in depth study of the major renewable policy developments across the globe. It gives regulatory and other associated updates for the global renewable energy market which can help the individual/company to frame their business strategies while minimizing regulatory risks. For the June 2013 issue, it covers two fe …
- 2014 Assessments of Leading Hematology and Flow Cytometry Market Players–Strategic Analyses of Major Suppliers and Emerging Market EntrantsThis new report from Venture Planning Group provides strategic assessments of major suppliers of hematology and flow cytometry instuments and reagants, as well as emerging market entrants. The report presents strategic analyses of the major current and emerging suppliers in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative a …
- グローバル機能性食品・飲料市場の将来分析Summary “The Future of Functional Food & Drinks - successful product positioning and claims” provides a comprehensive overview of the functional food and drink landscape, analyzing the regulatory and consumer drivers to identify the best opportunities and strategies. Innovation hubs are identified: Europe for regulation, Japan for product development, the US for consumer demand, and Brazil, India, …
- 皮下注射針の世界市場2016-2020About Hypodermic Needles A hypodermic needle is an integral part of healthcare for parenteral drug delivery and has been in regular use globally for more than five decades. The global hypodermic needles market has been witnessing continuous technological innovations and developments over the years. Technavio’s analysts forecast the global hypodermic needles market to grow at a CAGR of 6.83% during …
- 一酸化炭素（CO）警報装置の世界市場ABSTRACTAbout Carbon Monooxide Alarm CO alarms provide protection from inhaling CO gas by detecting the presence of CO gas and alerting with a sound produced by the alarm. Carbon monoxide (CO), also known as the silent killer, is an odorless and colorless toxic gas that is released when a fossil or fuel is burnt incompletely. It can cause various health hazards depending on the amount of gas inhal …
- 不織布ワイプの世界市場2015-2019About Non-woven Wipes Non-woven wipes are commonly used to clean surfaces. Non-woven material is more widely used in manufacturing wipes as they are less expensive, more versatile, and more hygienic than traditional woven material. TechNavio's analysts forecast the Global Non-woven Wipes market to grow at a CAGR of 6.65 percent over the period 2014-2019. [Covered in this Report] The Global Non-wov …
- ドア装置の世界市場：スイングドア、引戸、折戸、回転戸Consumers have become more concerned with their safety and security which results in the rise in demand for high security doors. Factors such as improving global economy, rapid urbanization, high disposable income, and growing middle class families in emerging countries such as China and India have increased the need for buildings. This in turn will stimulate the demand for door systems market. Th …
- キセノンガスの世界市場2015-2019About xenon gas Xenon is naturally available in the atmosphere in trace amounts and is extremely expensive to produce. Xenon is commercially extracted through atmospheric air distillation while some of its compounds are sourced from certain igneous rocks and hot springs. With about eight stable isotopes and more than 40 unstable isotopes, the gas, despite the limited availability and high price, i …
- ショート末梢静脈カテーテル（PIVC）の世界市場2017-2021About Short PIVC A short peripheral intravenous catheter (PIVC) is a long, thin tube that is used to inject fluid or medication directly into a vein or to draw blood samples for testing. A needle is inserted and subsequently removed from a peripheral vein (i.e., veins found in the arms, hands, legs, or feet), leaving a small tube (the cannula) at the insertion site. The catheter is then attached t …
- スマート水管理市場（グローバル市場予測及び分析）Utilities and governments across the globe are pressed with meeting the increasing demand of quality water and maintaining the aging infrastructure of water networks. Non-Revenue Water (NRW) accounts for a significant loss to water utilities financially due to leaks, theft, and metering errors. Smart Water Management (SWM) solutions are vital to water utilities facing such issues. SWM allows for s …
- グローバル金融サービス市場の景況感レポート（2014年第2四半期）• The report examines industry executives’ opinions about the current state of the global economy and prevailing economic conditions in various regions • The report analyzes the growth prospects of companies and the industry as a whole, providing industry executives’ expectations on the growth prospects of their company and the industry over April–June 2014 • The report analyzes industry executive …
- 術中神経モニタリング（IONM）の世界市場の規模と予測：タイプ別（インソースIONM、アウトソースIONM）、地域別（北アメリカ[米国、カナダ]、ヨーロッパ[英国、ドイツ]、アジア太平洋[日本、中国]、ラテンアメリカ[ブラジル、メキシコ]、MEA [南アフリカ]）、動向分析、2014-2025The global Intraoperative Neuromonitoring (IONM) market is expected to reach USD 3.6 billion by 2025, based on a new report by Grand View Research, Inc. The intraoperative neuromonitoring market is anticipated to witness significant growth in the forecast period, which can be attributed to the hospitals adopting intraoperative monitoring in a wide spectrum of surgeries. Major surgeries pose a risk …
